Sponge antiseptic with kanamycin (Sponge) Instructions for Use
Marketing Authorization Holder
Pechery Firm, LLC (Russia)
ATC Code
B02BC30 (Local hemostatics in combinations)
Active Substances
Nitrofural (Rec.INN registered by WHO)
Kanamycin (Rec.INN registered by WHO)
Dosage Form
| Sponge antiseptic with kanamycin | Sponge: sachet 1, 100, 200, or 300 pcs. |
Dosage Form, Packaging, and Composition
| Sponge | 1 g |
| Kanamycin monosulfate | 37500 IU |
| Nitrofural | 1.5 mg |
Excipients: calcium chloride, gelatin.
1 pc. – laminated paper bags (1) – cardboard packs.
1 pc. – laminated paper bags (100) – cardboard boxes.
1 pc. – laminated paper bags (200) – cardboard boxes.
1 pc. – laminated paper bags (300) – cardboard boxes.
Clinical-Pharmacological Group
Hemostatic agent for topical application
Pharmacotherapeutic Group
Combined antimicrobial agent
Pharmacological Action
Combined antimicrobial agent. It has antibacterial (against gram-positive and gram-negative microorganisms) and hemostatic action, stimulates reparative processes in the wound and accelerates its healing.
Pharmacokinetics
When applied to a wound, the sponge swells within 5-10 seconds and absorbs exudate in an amount 30-40 times its own weight. At the same time, a local depot of kanamycin is created, which, as the sponge dissolves under the action of proteolytic enzymes, enters the wound in a bactericidal concentration. Within 10-14 days, the sponge left in the wound completely dissolves.
Indications
Wounds, including infected wounds and burns of any etiology and location (as a means of individual protection when providing first aid); thermal, chemical and radiation burns of varying severity and location (for biological coverage as part of complex therapy); trophic ulcers; bone defect after sequestrectomy for osteomyelitis; prevention of postoperative complications and development of wound infection; bleeding (including capillary, parenchymal, occurring during surgical interventions and injuries); in dentistry: stopping socket bleeding in hemophilia.
ICD codes
| ICD-10 code | Indication |
| L98.4 | Chronic skin ulcer, not elsewhere classified |
| M86 | Osteomyelitis |
| R58 | Hemorrhage, not elsewhere classified |
| T14.1 | Open wound of unspecified body region |
| T30 | Burns and corrosions of unspecified body region |
| T79.3 | Posttraumatic wound infection, not elsewhere classified |
| T88.8 | Other specified complications of surgical and medical care, not elsewhere classified |
| Z29.8 | Other specified prophylactic measures |
| ICD-11 code | Indication |
| EA40 | Tropical phagedenic ulcer |
| EF60 | Ischemic ulceration of the skin |
| EM0Z | Unspecified skin disorder |
| FB84.Z | Osteomyelitis or osteitis, unspecified |
| ME60.2 | Ulcerative skin lesion of unspecified nature |
| MG27 | Hemorrhage, not elsewhere classified |
| ND56.1 | Open wound of unspecified body region |
| NE11 | Burn of unspecified body region |
| NE8Z | Injury or harm caused as a result of surgical or therapeutic interventions, not elsewhere classified, unspecified |
| NF0A.3 | Posttraumatic wound infection, not elsewhere classified |
| QC05.Z | Prophylactic measures, unspecified |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Apply topically to the affected area.
Determine the amount of sponge used by the size and area of the wound surface.
Ensure the sponge completely covers the wound, with edges extending slightly onto intact skin.
For heavily exuding wounds, apply multiple layers to ensure adequate absorption.
The total amount of kanamycin with a single use must not exceed 1 million IU.
For extensive wound surfaces, calculate the maximum number of sponges based on this limit.
Leave the sponge in the wound; do not remove it.
The sponge will swell upon application and subsequently dissolve completely within 10-14 days.
Adverse Reactions
Possible: allergic reactions.
Contraindications
Hypersensitivity to the components of the drug, pregnancy, breastfeeding period, childhood.
Use in Pregnancy and Lactation
Use during pregnancy and breastfeeding is contraindicated.
Pediatric Use
Use in children is contraindicated.
Geriatric Use
The drug is approved for use in elderly patients.
Special Precautions
The use of the sponge does not require its subsequent removal (the sponge left in the wound dissolves on its own).
Storage Conditions
Store at 2°C (36°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer